Quantum BioPharma News - August 11, 2026

🟢 Quantum BioPharma is trading 5% up today after FDA approval moved Lucid-MS into Phase 2

Quantum BioPharma is trading at $3.64 (+5.20%) after the FDA approved its Investigational New Drug application for Lucid-MS on August 10, 2026, allowing the...

🟢 Quantum BioPharma is trading 8.38% up in pre-market after FDA cleared Lucid-MS for Phase 2 development

Quantum BioPharma is trading 8.38% up at $3.75 after the FDA approved its Investigational New Drug application for Lucid-MS on August 10, 2026, allowing the...